1 Min Read
May 8 (Reuters) - Horizon Pharma PLC:
* HORIZON PHARMA PLC - ANNOUNCES U.S. PATENT AND TRADEMARK OFFICE ISSUANCE OF ADDITIONAL NOTICES OF ALLOWANCE WITH CLAIMS COVERING RAVICTI ORAL LIQUID Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.